Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2024 Apr 22;30(6):1785. doi: 10.1038/s41591-024-03006-6

Author Correction: Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants

Deidre Wilkins 1,, Yuan Yuan 1, Yue Chang 1, Anastasia A Aksyuk 1, Beatriz Seoane Núñez 2, Ulrika Wählby-Hamrén 3, Tianhui Zhang 4, Michael E Abram 1, Amanda Leach 5, Tonya Villafana 6, Mark T Esser 6
PMCID: PMC11186749  PMID: 38649782

Correction to: Nature Medicine 10.1038/s41591-023-02316-5, published online 24 April 2023.

In the version of the article initially published, in the Fig. 6a Phase 2b, Nirsevimab pie chart, “(n = 294)” has been corrected from “(n = 134)” in the HTML and PDF versions of the article.


Articles from Nature Medicine are provided here courtesy of Nature Publishing Group

RESOURCES